Company Name:DBV Technologies S.A.
CEO: Daniel Tassé

Sector: Healthcare
Industry:Biotechnology

Exchange: Nasdaq Global Select

Country: USA

Description: DBV Technologies SA is a biopharmaceutical company. It is engaged in research and development of patient-friendly therapy for food and pediatric allergy patients.


Key numbers

Market Capitalization:721791729
Shares Outstanding: 93983298
Float: 93713471.951442
Next Earning Date:2020-03-23
TTm EPS: -3.1682
TTm Dividend Rate:
200 days moving average:8.68
50 days moving average: 8.13
One day percent Change: -2.99



2017-06-30, 2017-12-31, 2018-06-30, 2018-12-31,
2017-06-30, 2017-12-31, 2018-06-30, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,